WallStSmart

JPMorgan Chase & Co (JPM)vsMetLife Inc (MET)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JPMorgan Chase & Co generates 124% more annual revenue ($173.56B vs $77.58B). JPM leads profitability with a 33.9% profit margin vs 4.7%. MET appears more attractively valued with a PEG of 0.43. JPM earns a higher WallStSmart Score of 73/100 (B).

JPM

Strong Buy

73

out of 100

Grade: B

Growth: 8.0Profit: 8.0Value: 5.7Quality: 3.0
Piotroski: 4/9Altman Z: 0.55

MET

Strong Buy

68

out of 100

Grade: B-

Growth: 6.0Profit: 5.0Value: 7.7Quality: 6.8
Piotroski: 4/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JPM5 strengths · Avg: 9.2/10
Market CapQuality
$806.43B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
33.9%10/10

Keeps 34 of every $100 in revenue as profit

Operating MarginProfitability
43.7%10/10

Strong operational efficiency at 43.7%

P/E RatioValuation
14.4x8/10

Attractively priced relative to earnings

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

MET6 strengths · Avg: 8.5/10
PEG RatioValuation
0.4310/10

Growing faster than its price suggests

Market CapQuality
$53.29B9/10

Large-cap with strong market position

P/E RatioValuation
16.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

EPS GrowthGrowth
35.9%8/10

Earnings expanding 35.9% YoY

Free Cash FlowQuality
$2.69B8/10

Generating 2.7B in free cash flow

Areas to Watch

JPM4 concerns · Avg: 2.3/10
PEG RatioValuation
1.574/10

Expensive relative to growth rate

Free Cash FlowQuality
$-211.76B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.552/10

Distress zone — elevated risk

Debt/EquityHealth
3.391/10

Elevated debt levels

MET2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : JPM

The strongest argument for JPM centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 33.9% and operating margin at 43.7%. Revenue growth of 12.7% demonstrates continued momentum.

Bull Case : MET

The strongest argument for MET centers on PEG Ratio, Market Cap, P/E Ratio. PEG of 0.43 suggests the stock is reasonably priced for its growth.

Bear Case : JPM

The primary concerns for JPM are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 3.39 is elevated, increasing financial risk.

Bear Case : MET

The primary concerns for MET are Revenue Growth, Profit Margin. Thin 4.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

JPM profiles as a mature stock while MET is a value play — different risk/reward profiles.

JPM carries more volatility with a beta of 1.02 — expect wider price swings.

JPM is growing revenue faster at 12.7% — sustainability is the question.

MET generates stronger free cash flow (2.7B), providing more financial flexibility.

Bottom Line

JPM scores higher overall (73/100 vs 68/100), backed by strong 33.9% margins and 12.7% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JPMorgan Chase & Co

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

JPMorgan Chase & Co. is an American multinational investment bank and financial services holding company headquartered in New York City. JPMorgan Chase is incorporated in Delaware. As a Bulge Bracket bank, it is a major provider of various investment banking and financial services. It is one of America's Big Four banks, along with Bank of America, Citigroup, and Wells Fargo. JPMorgan Chase is considered to be a universal bank and a custodian bank. The J.P. Morgan brand is used by the investment banking, asset management, private banking, private wealth management, and treasury services divisions.

Visit Website →

MetLife Inc

FINANCIAL SERVICES · INSURANCE - LIFE · USA

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with 90 million customers in over 60 countries.

Want to dig deeper into these stocks?